# Gabriel Jones

> Gabriel Jones is the co-founder and CEO of Proprio, a Seattle medtech company building AI-powered surgical navigation. Its FDA-cleared Paradigm platform combines light-field imaging, real-time AI, and 3D visualization to give surgeons dynamic spatial awareness during spine procedures. Jones took an unusual path to medtech - engineering study in Japan, civil engineering at Taisei, Wall Street M&A, and work with the Bill & Melinda Gates Foundation - before co-founding Proprio in 2016 with a neurosurgeon, a robotics professor, and a computer vision specialist. He frames the mission around a single question: is it possible to do well and do good?

- **Role:** Co-founder and CEO at Proprio
- **Organizations:** Proprio, Bill & Melinda Gates Foundation (former), Taisei Corporation (former)
- **Nationality:** American
- **Education:** Engineering (Japan-based program covering mechanical, electrical engineering, and computer science), University of Washington
- **Known for:** Co-founded Proprio in 2016 and grew it to roughly 70 employees, Led Proprio to FDA 510(k) clearance for the Paradigm surgical navigation platform in April 2023, Raised a $43M Series B (total funding around $78M)

## Career timeline

- **Early career** — Studied engineering at the University of Washington through a Japan-based program taught by Japanese professors
- **Early career** — Worked at Taisei, one of Asia's largest civil engineering firms, as its only non-Japanese employee
- **Mid career** — Moved to Washington, DC to study legal systems and governance, then to Wall Street for large-scale M&A serving clients including AT&T and Google
- **Pre-Proprio** — Returned to Seattle and worked with the Bill & Melinda Gates Foundation on global health initiatives, including special projects with Bill Gates
- **2016** — Co-founded Proprio with Dr. Samuel Browd, Joshua Smith, and James Youngquist
- **2020** — Raised Series A during the first wave of the COVID-19 pandemic
- **2023-04** — Proprio received FDA 510(k) clearance for its Paradigm platform for spine surgery
- **2023-07** — Closed a $43M Series B round (total funding reported at ~$78M)

## Achievements

- Co-founded Proprio in 2016 and grew it to roughly 70 employees
- Led Proprio to FDA 510(k) clearance for the Paradigm surgical navigation platform in April 2023
- Raised a $43M Series B (total funding around $78M)
- Assembled a board and advisory group including former Globus Medical CEO Dave Demski and computer vision pioneer Takeo Kanade
- Recognized in the TITAN Innovation Awards

## Latest updates

- **2023-04** — Proprio received FDA 510(k) clearance for its Paradigm platform for spine surgery.
- **2023-07** — Proprio closed a $43M Series B round to scale its surgical navigation platform.

## Links

- Website: https://propriovision.com
- LinkedIn: http://www.linkedin.com/in/agabrieljones
- Twitter/X: https://twitter.com/Proprio_Vision
- YouTube: https://www.youtube.com/watch?v=8Op0MhYbbrI

---

Profile page: https://yespress.io/gabriel-jones
Published by YesPress — https://yespress.io
Last updated: 2026-07-17